User profiles for Ian P Sinha
 | ian sinhauniversity of liverpool alder hey children's hospital Verified email at liv.ac.uk Cited by 7179 |
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
Objective To characterise the clinical features of children and young people admitted to
hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
[HTML][HTML] Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing …
IP Sinha, RL Smyth, PR Williamson - PLoS medicine, 2011 - journals.plos.org
Ian Sinha and colleagues advise that when using the Delphi process to develop core
outcome sets for clinical trials, patients and clinicians be involved, researchers and facilitators …
outcome sets for clinical trials, patients and clinicians be involved, researchers and facilitators …
[HTML][HTML] COVID-19 infection in children
With rates of hospitalisation and mortality from novel coronavirus disease 2019 (COVID-19)
increasing, there is understandable concern across the UK for medical professionals and the …
increasing, there is understandable concern across the UK for medical professionals and the …
[HTML][HTML] Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people
IP Sinha, R Gallagher, PR Williamson, RL Smyth - Trials, 2012 - Springer
Background In clinical trials in childhood asthma, outcomes reflecting short-term disease
activity are frequently measured, whilst functional status, quality of life (QoL), and long-term …
activity are frequently measured, whilst functional status, quality of life (QoL), and long-term …
[HTML][HTML] Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients
Background: Reports of ethnic inequalities in COVID-19 outcomes are conflicting and the
reasons for any differences in outcomes are unclear. We investigated ethnic inequalities in …
reasons for any differences in outcomes are unclear. We investigated ethnic inequalities in …
CPAP and high-flow nasal cannula oxygen in bronchiolitis
IP Sinha, AKS McBride, R Smith, RM Fernandes - Chest, 2015 - Elsevier
… Author links open overlay panel Ian P. Sinha PhD a , Antonia KS McBride MBChB a , …
increasing the flow from 1 to 7 L/min was associated with a significant decrease in RR (P =. 007) …
increasing the flow from 1 to 7 L/min was associated with a significant decrease in RR (P =. 007) …
Corticosteroids for treating hypotension in preterm infants
H Ibrahim, IP Sinha… - Cochrane Database of …, 2011 - cochranelibrary.com
Background Systemic hypotension is a relatively common complication of preterm birth and
is associated with periventricular haemorrhage, periventricular white matter injury and …
is associated with periventricular haemorrhage, periventricular white matter injury and …
Child poverty, food insecurity, and respiratory health during the COVID-19 pandemic
IP Sinha, AR Lee, D Bennett, L McGeehan… - The Lancet …, 2020 - thelancet.com
The eradication of poverty and hunger are the top sustainable development goals, adopted
by UN Member States in 2015. Yet the World Food Programme estimates that, in the wake of …
by UN Member States in 2015. Yet the World Food Programme estimates that, in the wake of …
Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children
People making choices in health care should use the findings of clinical trials (ideally,
incorporated in systematic reviews) to inform their decisions. If these findings are to be useful and …
incorporated in systematic reviews) to inform their decisions. If these findings are to be useful and …
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis
Background Cystic fibrosis (CF) is a common life‐shortening condition caused by mutation
in the gene that codes for that codes for the cystic fibrosis transmembrane conductance …
in the gene that codes for that codes for the cystic fibrosis transmembrane conductance …
